SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
all12089-sup-0001-FigureS1.tifimage/tif1188KFigure S1. Identification of 10 mAbs binding OVM and OVA.
all12089-sup-0002-FigureS2.tifimage/tif752KFigure S2. PSA induction by 10 mAbs and OVA.
all12089-sup-0003-FigureS3.tifimage/tif5882KFigure S3. Primary data corresponding to the PCA induction displayed in Table 2.
all12089-sup-0004-FigureS4.tifimage/tif2350KFigure S4. Primary data (for Table 2) corresponding to the down-regulation of murine blood neutrophil CD16/32.

Figure S5. The relationship between decline of rectal temperature and down-regulation of murine neutrophil CD16/32 expression.

all12089-sup-0005-FigureS5.tifimage/tif1123KFigure S5. The relationship between decline of rectal temperature and down-regulation of murine neutrophil CD16/32 expression.
all12089-sup-0006-TableS1-S4.docWord document261K

Table S1. Antigens and mAbs used in murine PSA.

Table S2. The list of mAbs generated with OVA as the immunogen.

Table S3. Analysis of distinct epitope binding to anti-OVM mAbs by competition ELISA.

Table S4. Ag-mAb doses for PSA, PCA and induction of neutrophil CD16/32 down-regulation.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.